Skip to main content
OpenTrials

Clinical trial condition

Retinal Vein Occlusion

Explore clinical trials studying Retinal Vein Occlusion. Study availability and eligibility vary by location and protocol.

188 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Retinal Vein Occlusion trial results

Completed

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

NCT04264819

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 51 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

NCT04740931

Conditions
Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +10 more
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 194 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

NCT04740905

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +9 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
  • Retinal Diagnostic Center Campbell, California, United States
  • The Retina Partners Encino, California, United States
View all 150 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT04592419

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +16 more
Locations
  • Northwest Arkansas Retina Associates Phoenix, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Vitreous Associates Beverly Hills, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
View all 141 locations
View Trial Details
Completed

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

NCT03927690

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +22 more
Locations
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Rancho Cordova, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site ‘Aiea, Hawaii, United States
View all 22 locations
View Trial Details

Related conditions